MD Medical Group announces Board of Directors changes

6 December 2019, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG),), a leading Russian private healthcare provider, today announces changes in its Board of Directors.

Tatyana Lukina and Tony Mayer were appointed as Independent Non-Executive Directors for the vacant positions in BoD. The changes came into force on 06 December 2019.

Ms Tatiana Lukina brings to the Company her 18 years of experience in finance, business restructuring and project management in a wide range of industries.

Since 2016 Ms Lukina has been working as a CFO at GAME INSIGHT, a global mobile game developing company. Tatiana's career has commenced in KPMG, where during 10 years she participated and led projects in audit, capital markets transactions (IPO, SPO, Eurobons) in international stock exchanges, debt restructuring for major Russian companies, M&A transaction services in different countries. After that Tatiana worked in the Portfolio Asset Management department at ALFA Group, represented shareholders in Boards and Committees of ALFA bank (Russia, Ukraine, Kazakhstan) and Rosvodokanal. In 2015-2016 Tatiana as a co-leader of finance headed an IPO preparatory project at OZON.ru, a leading on-line retailer in Russia.

Ms Lukina graduated from the Financial Academy of the Russian Government with a 1st-class honour degree in Finance, Business Appraisal and Turnaround Management and then finished her PhD there.

Since 2006 Tatiana is a member of the Association of Certified Chartered Accountants (ACCA) in the UK, successfully passed exams for a Russian Audit License.

Mr Tony Maher brings to the Group more than 40 years of experience in the consumer sector.

Mr Maher’s other current appointments include the positions of Chairman at Progress, Russia’s largest baby food company, since 2012; Chairman at LPQ Russia Limited, a restaurant chain operator, since 2015; Board member at Detsky Mir, the largest children's goods retailer in Russia and the CIS, since 2018; and Director of Da Vinci Capital, a leading independent investment manager, since 2012.

Mr Maher previously served as CEO of Wimm-Bill-Dann, the leading producer of dairy, baby food and beverage products in Russia, and held various positions at Coca-Cola in a number of countries.

Mr Maher holds a B.A. Honours degree in Management from The National Council for Education in Ireland.

Mark Kurtser, CEO of MD Medical Group, said:

“We are pleased to announce that two new members have joined the Board as independent directors and are confident that their extensive experience in managing major projects in various spheres will contribute to the further development of the Company”.